ARTICLE | Clinical News
Oxaydo regulatory update
December 7, 2016 10:29 PM UTC
Egalet said it submitted an sNDA to FDA for oral Oxaydo oxycodone to support an abuse-deterrent label claim for the IV route of abuse. Oxaydo is approved to manage acute and chronic moderate to severe...
BCIQ Target Profiles